Context Therapeutics Inc.
Context Therapeutics Inc. (CNTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CNTX · as of Jun 8, 2026
Key Statistics
Explore Context Therapeutics Inc. Data
cntx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The CNTX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $5.25, representing +207.02% upside from the current price of $1.71.
Competitors & Peers
cntx competitorsCNTX
CLNN
CNTB
IFRX
IMA
KLRSStock Performance
Full HistoryAbout Context Therapeutics Inc.
Context Therapeutics Inc. (CNTX) is a biopharmaceutical firm in the clinical development stage, dedicated to advancing cancer treatments specifically for women in the United States. Its leading invest…
what is context therapeutics inc. · cntx stock overview · context therapeutics inc. company profile · who is context therapeutics inc. ceo · cntx NASDAQ · context therapeutics inc. headquarters · context therapeutics inc. business segments
About Stock Overview & Key Data
Context Therapeutics Inc. (CNTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 20, 2021. As of the latest trading session, CNTX stock price is $1.71, with a market capitalization of $157.1M. The stock has returned +143.28% over the past 12 months and +16.33% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Context Therapeutics Inc. stock is Buy, with an average 12-month price target of $5.25. In fiscal year 2025, Context Therapeutics Inc. reported revenue of — and net income of -$36.1M. For detailed data — including Context Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Context Therapeutics Inc. (CNTX) stock price is $1.71. The stock is traded on NASDAQ under the ticker symbol CNTX. The 52-week range is $0.54 – $3.62.